Outcomes following immunosuppressive therapy withdrawal after complete renal response in proliferative lupus nephritis
Objective To investigate the rate and factors influencing renal relapse (RR) in proliferative lupus nephritis (LN) patients who discontinued immunosuppressive therapy (IST), as well as the long-term renal outcomes following RR.Methods Retrospective, single-centre study of biopsy-confirmed LN patient...
Saved in:
Main Authors: | Javier Narváez, Francesca Mitjavila, Joan M Nolla, Paola Vidal-Montal, Montserrat Gomà, Xavier Fulladosa, Olga Capdevila, Joan Torras |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Lupus Science and Medicine |
Online Access: | https://lupus.bmj.com/content/12/1/e001375.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is renal biopsy always necessary to start immunosuppressive therapy in lupus nephritis?
by: Vasudevan Chelliah, et al.
Published: (2017-01-01) -
STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis
by: Jianfen Zhu, et al.
Published: (2024-12-01) -
Classifying Lupus Nephritis: An Ongoing Story
by: Saba Kiremitci, et al.
Published: (2014-01-01) -
Renal biopsy in lupus nephritis: To do or not to do?
by: Manish Rathi, et al.
Published: (2017-01-01) -
Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis
by: Jing Xue, et al.
Published: (2017-01-01)